Multiple Sclerosis (MS) Information, and resources https://validator.w3.org/feed/docs/rss2.html Hilton Garden Inn Dayton/Beavercreek Blog MS Views and News Donate Jerry Kamer, Director of Finance Signs of multiple sclerosis show up in blood years before symptoms, study finds Aaron L. Boster, MD Vitamin D Deficiency in Adults: Symptoms, Treatments, and Related Health Conditions How to Get Through an MRI if You’re Claustrophobic An MS Patient’s Experience and Journey with MS Neurologist Heidi Crayton, MD MS patients less likely to have Alzheimer’s, study finds APOE4 gene variant linked to greater nerve damage in MS: Study High Epstein-Barr antibody levels over time may aid MS diagnosis Stopping Ocrevus in stable MS doesn’t seem to raise 2-year risk, study finds Talking Biosimilars – Unlocking Patient access through coordinated action How MS Can Affect Your Oral Health Myelin Restoration and Stem Cell therapy Updates PLUS other Need to know MS topics – In Dayton OH Online Survey: Stress and MS – from the National MS Society High-Altitude Gene Helps Heal Myelin Damage (New Date) Understanding Disability Progression in MS + Functional Therapy – Huntsville ESTATE PLANNING And LEGAL HEALTHCARE Documenation The MS Patient’s Journey (with Dr. Crayton) (at McCormick & Schmick’s by Reagan Airport) MS Patient and Carepartner Special event in Boca Raton (No SEATS available) Understanding Brain Health, Exercise and MS Progression – Atlanta Multiple Sclerosis in Spanish / Esclerosis Múltiple en Español 2026 – MS WELLNESS SUMMIT -(March 15, 2026) – with Boster, Siracusa and Motl Embassy Suites by Hilton – Boca Raton Beyond One Drug: What the Tolebrutinib Decision Teaches Us About Progressive MS Trials. 2026 MS WELLNESS SUMMIT in Columbus, OH (near airport) Pseudobulbar affect in MS Catch-up on Our Mental Wellness Chat Series High-dose vitamin D can help delay progression to MS Having parents who smoked increases risk of pediatric MS: Study MRI and MS diagnosis Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1) Eating well with MS can be an effective in managing symptoms Ocrevus and Tysabri appear to work equally well to control relapsing MS Multiple Sclerosis in Spanish / Esclerosis Múltiple en Español (cerca del Aeropuerto Miami) MYELIN RESTORATION and STEM CELL THERAPY UPDATES (Virtual) (event closed) Compass to MS Care – Myelin Restoration and Stem Cell therapy Updates Predictors of initiating high-efficacy vs. platform therapies as first-line disease-modifying treatment in multiple sclerosis Japanese researchers build robotic tail to keep elderly upright Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs Scientists find the Brain’s “Reset Switch” that breaks life into separate memories (No more seats available) Understanding SMOLDERING MS (PIRA) and MS Progression – Tampa Welcome to The Brain Health Minute, where science meets action, one minute at a time. Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial Resources Links Expert Panel Publishes Revised Consensus Recommendations for Diagnosis and Management of NMOSD MS Trial Alert: Investigators Recruiting Nationwide for Study Comparing AHSCT to Other Therapies in Active Relapsing MS